Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.

Uner B, Ozdemir S, Tas C, Uner M, Ozsoy Y

Open source

DOI
10.1208/s12249-023-02551-6
Published
2023 Mar 28
Container
AAPS PharmSciTech
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1208/s12249-023-02551-6,
  title = {Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.},
  author = {Uner B and Ozdemir S and Tas C and Uner M and Ozsoy Y},
  year = {2023},
  journal = {AAPS PharmSciTech},
  doi = {10.1208/s12249-023-02551-6},
  url = {https://doi.org/10.1208/s12249-023-02551-6}
}

RIS

TY  - JOUR
TI  - Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.
AU  - Uner B
AU  - Ozdemir S
AU  - Tas C
AU  - Uner M
AU  - Ozsoy Y
PY  - 2023
JO  - AAPS PharmSciTech
DO  - 10.1208/s12249-023-02551-6
UR  - https://doi.org/10.1208/s12249-023-02551-6
ER  - 

APA

B, U., S, O., C, T., M, U., & Y, O. (2023). Loteprednol-Loaded Nanoformulations for Corneal Delivery by Quality-by-Design Concepts: Optimization, Characterization, and Anti-inflammatory Activity.. AAPS PharmSciTech. https://doi.org/10.1208/s12249-023-02551-6

Source records